Biopharma & Investment Partnerships Panel — Exploring the Future of RNA Investment & Collaborations Space for Small Molecules
Time: 11:00 am
day: Day One
The biopharmaceutical sector is considering small molecule medications as a vital component. This community thrives on strategic alliances, which allow for cross-functional sharing of knowledge, skills, and experience across different disciplines to truly advance RNA-targeted small molecule drugs to patients. This session is the ideal opportunity to get face-to-face time with many of the brightest minds working in the RNA small molecule field and establish meaningful business relationships to pursue for the rest of the conference.
- Exploring the complexities, risk, and decision-making strategies for developing, acquiring, and advancing innovative approaches
- Where are the gaps using RNA-targeting small molecule approaches that the biotechnology sector can fill?
- Developing successful expertise in house vs asset acquisition partnering strategies